8 Coupons
-
Special Offer
-
30% off
.
., and bones, and it�s not clear how the drugs will affect them after long-term use.
.
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr. .
may 16, 2018
.